Alanine and terbutaline in the prevention of nocturnal hypoglycemia in IDDM

Diabetes Care

Volumn 20, Issue 8, 1997, Pages 1231-1236

  Saleh, Tarek Y ^a   Cryer, Philip E ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; TERBUTALINE;

ARTICLE; CLINICAL ARTICLE; DRUG EFFECT; GLUCAGON RELEASE; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; NIGHT;

EID: 0030762452     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.20.8.1231     Document Type: Article

References (25)

1. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
2. The Diabetes Control and Complications Trial Research Group: Epidemiology of severe hypoglycemia in the Diabetes Control and Complications Trial. Am J Med 90:450-459, 1991
3. The Diabetes Control and Complications Trial Research Group: Adverse events and their association with treatment regimens in the Diabetes Control and Complications Trial. Diabetes Care 18:1415-1427, 1995
4. Cryer PE, Fisher JN, Shamoon H: Hypoglycemia. Diabetes Care 17:734-735, 1994
5. Kerner W, Navascués I, Torres AA, Pfeiffer EF: Studies on the pathogenesis of the dawn phenomenon in insulin-dependent diabetic patients. Metabolism 33:458-464, 1984
6. Perriello G, De Feo P, Torlone E, Fanelli C, Santeusanio F, Brunetti P, Bolli G: The dawn phenomenon in type 1 (insulin-dependent) diabetes mellitus: magnitude, frequency, variability and dependency on glucose counterregulation and insulin sensitivity. Diabetologia 34:21-28, 1991
7. Boyle PJ, Avogaro A, Smith L, Shah SD, Cryer PE, Santiago JV: Absence of the dawn phenomenon and abnormal lipolysis in type 1 (insulin-dependent) diabetic patients with chronic growth hormone deficiency. Diabetologia 35:372-379, 1992
8. White NH, Skor DA, Cryer PE, Bier DM, Levandoski L, Santiago JV: Identification of type 1 diabetic patients at increased risk for hypoglycemia during intensive therapy. N Engl J Med 308:485-491, 1983
9. Bolli GB, De Feo P, De Cosmo S, Perriello G, Ventura MM, Benedetti MM, Santeusanio F, Gerich JE, Brunetti P: A reliable and reproducible test for adequate glucose counterregulation in type I diabetes mellitus. Diabetes 33:732-737, 1984
10. Sjöbom NC, Adamson U, Lins PE: The prevalence of impaired glucose counterregulation during an insulin infusion test in insulin-treated patients prone to severe hypoglycaemia. Diabetologia 32:818-825, 1989
11. Cryer PE: Hypoglycemia: the limiting factor in the management of IDDM. Diabetes 43:1378-1389, 1994
12. Wiethop By Cryer PE: Glycemic actions of alanine and terbutaline in IDDM. Diabetes Care 16:1124-1130, 1993
13. Wiethop BV, Cryer PE: Alanine and terbutaline in the treatment of hypoglycemia in IDDM. Diabetes Care 16:1131-1136, 1993
14. Shah S, Clutter W, Cryer PE: External and internal standards in the single isotope derivative (radioenzymatic) assay of plasma norepinephrine and epinephrine in normal humans and patients with diabetes mellitus or chronic renal failure. J Lab Clin Med 106:624-629, 1985
15. Gingerich R, Lacy P, Chance R, Johnson M: Regional pancreatic concentration and in vivo secretion of canine pancreatic polypeptide, insulin and glucagon. Diabetes 27:96-101, 1978
16. Kuzkuya H, Blix P, Horwitz D, Steiner D, Rubenstein A: Determination of free and total insulin and C-peptide in insulin-treated diabetics. Diabetes 26:22-29, 1977
17. Ensinck J: Immunoassays for glucagon. In Handbook of Experimental Pharmacology. Vol. 66. Lefebrve P, Ed. New York, Springer-Verlag, 1983, p. 203-221
18. Schalch D, Parker M: A sensitive double antibody radioimmunoassay for growth hormone in plasma. Nature 703:1141-1142, 1964
19. Farmer R, Pierce C: Plasma cortisol determination: radioimmunoassay and competitive binding compared. Clin Chem 20:411-414, 1974
20. Hosaka K, Kikuchi T, Mitsuhida N, Kawaguchi A: A new calorimetric method for the determination of free fatty acids with acyl-CoA synthetase and acyl-CoA oxidase. J Biochem 89:1799-1803, 1982
21. Lowry O, Passoneau J, Hasselberger F, Schultz D: Effect of ischemia on known substrates and co-factors of the glycolytic pathway of the brain. J Biol Chem 239:18-30, 1964
22. Pinter J, Hayaski J, Watson J: Enzymatic assay of glycerol, dihydroxyacetone and glyceraldehyde. Arch Biochem Biophys 121:404-414, 1967
23. Cahill G, Herrera M, Morgan A, Soeldner J, Steinke J, Levy P, Reichard G, Kipnis D: Hormone-fuel interrelationships during fasting. J Clin Invest 45:1751-1769, 1966
24. Winiger G, Keller U, Laager R, Girard J, Berger W: Protein content of the evening meal and nocturnal plasma glucose regulation in type I diabetic subjects. Horm Res 44:101-104, 1995
25. Kaufman F, Halvorson M, Kaufman N: A snack bar containing uncooked cornstartch to diminish hypoglycemia (Abstract). Diabetes 45:56A, 1996